1Beecher, CW. Cancer preventive properties of varieties of Brassica oleracea: a review. Am. J. Clin. Nutr. 1994; 59: 1166S–70S.
2Block, G, Patterson, B, Subar, A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 1992; 18: 18–1.
3Steinmetz, KA, Potter, JD. Vegetables, fruit, and cancer prevention: a review. J. Am. Diet. Assoc. 1996; 96: 1027–39.
4Michaud, DS, Spiegelman, D, Clinton, SK, Rimm, EB, Willett, WC, Giovannucci, EL. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J. Natl. Cancer Inst. 1999; 91(7): 605–13.
5Verhoeven, DT, Goldbohm, RA, van Poppel, G, Verhagen, H, van denBrandt, PA. Epidemiological studies of Brassica vegetables and cancer risk. Cancer Epidemiol. Biomark. Prev. 1996; 5: 733–48.
6Kohlmeier, L, Su, L. Cruciferous vegetable consumption and colorectal cancer risk: meta-analysis of the epidemiological evidence. FASEB J. 1997; 11(3), 2141.
7Graham, S, Dayai, H, Swanson, M, Mittleman, A, Wilkinson, G. Diet in the epidemiology of cancer of the colon and rectum. J. Natl. Cancer Inst. 1978; 61(3): 709–14.
8Zhang, S, Hunter, D, Forman, MR, Rosner, BA, Speizer, FE, Colditz, GA, et al. Dietary carotenoids and vitamin A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 1999; 91(6): 547–56.
9Rosa, EAS, Heany, RK, Fenwick, GR, Portas, CAM. Glucosinolates in crop plants. Horticult. Rev. 1997; 19: 19–99.
10Fahey, JW, Zalcmann, AT, Talalay, P. The chemical diversity and distribution of glucosinolates among plants. Phytochemistry 2001; 56: 56–5.
11Shapiro, TA, Fahey, JW, Wade, KL, Stephenson, KK, Talalay, P. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of Cruciferous vegetables. Cancer Epidemiol. Biomark. Prev. 1998; 7: 1091–1100.
12Cover, CM, Hseih, SJ, Tran, SH, Hallden, G, Kim, GS, Bjeldanes, LF, et al. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J. Biol. Chem. 1998; 273(7): 3838–47.
13Vang, O, Frandsen, H, Hansen, KT, Nielsen, JB, Andersen, O. Modulation of drug-metabolising enzyme expression by condensation products of indole-3-ylcarbinol, and inducer in cruciferous vegetables. Pharmacol. Toxicol. 1999; 84: 84–59.
14Fares, FA, Ge, X, Yanni, S, Rennert, G. Dietary indole derivatives induce apoptosis in human breast cancer cells. Adv. Exp. Med. Biol. 1998; 451: 451–153.
15Fahey, JW, Stephenson, KK. Cancer chemoprotective effects of cruciferous vegetables. Horticult. Sci. 1999; 34(7): 1159–63.
16Prestera, T, Talalay, P. Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA 1995; 92: 92–8965.
17Talalay, P. The war against cancer: new hope. Proc. Am. Phil. Soc. 1999; 143(1): 52–72.
18Kensler, TW. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Persp. 1997; 105(Suppl.): 964–70.
19Fahey, JW, Talalay, P. Antioxidant functions of sulforaphane: a potent inducer of phase 2 detoxication enzymes. Food Chem. Tox. 1999; 37(9): 973–9.
20Willett, W. Nutritional Epidemiology. New York: Oxford University Press, 1990.
21Hebert, JR, Clemow, L, Pbert, L, Ockene, IS, Ockene, JK. Social desirability bias in dietary self-report may compromise the validity of dietary intake measures. Int. J. Epidemiol. 1995; 24(2): 389–98.
22Zhang, Y, Wade, KL, Prestera, T, Talalay, P. Quantitative determination of isothiocyanates, dithiocarbamates, carbon disulfide, and related thiocarbonyl compounds by cyclocondensation of 1,2-benzenedithiol. Anal. Biochem. 1996; 239: 239–160.
23Seow, A, Shi, C-Y, Chung, F-L, Jiao, D, Hankin, JH, Lee, H-P, et al. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol. Biomark. Prev. 1998; 7: 775–81.
24Kaaks, R, Riboli, E, Sinha, R. Biochemical markers of dietary intake. In: Toniolo, P, Boffetta, P, Shuker, D, Rothman, N, Hulka, B, Pearce, N, eds. Application of Biomarkers in Cancer Epidemiology. Lyon: IARC, 1997; 103–26.
25Getahun, SM, Chung, F-L. Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol. Biomark. Prev. 1999; 8: 8–447.
26Chung, F-L, Jiao, D, Getahun, SM, Yu, MC. A urinary biomarker for uptake of dietary isothiocyanates in humans. Cancer Epidemiol. Biomark. Prev. 1998; 7: 7–103.
27Chung, F-L, Morse, MA, Eklind, KI, Lewis, J. Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol. Biomark. Prev. 1992; 1: 1–383.
28Goodrich, RM, Anderson, JL, Stoewsand, GS. Glucosinolate changes in blanched broccoli and Brussels sprouts. J. Food Process. 1989; 13: 13–275.
29Kushad, MM, Brown, AF, Kurlich, AC, Juvik, JA, Klein, BP, Wallig, MA, et al. Variation of glucosinolates in vegetable crops of the Brassica oleracea. J. Agric. Food Chem. 1999; 47(4): 1541–8.
30Nugon-Baudon, L, Rabot, S. Glucosionolates and glucosinolate derivatives: implications for protection against chemical carcinogenesis. Nutr. Res. Rev. 1994; 7: 7–205.
31London, SJ, Yuan, J-M, Chung, FL, Gao, Y-T, Coetzee, BA, Ross, RK, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung cancer risk: a prospective study of men in Shanghai, China. Lancet 2000; 356: 724–9.
32Fowke, JH, Longcope, C, Hebert, JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomark. Prev. 2000; 9: 773–9.
33Feskanich, D, Sielaff, B, Chong, K, Buzzard, I. Computerized collection and analysis of dietary intake information. Comput. Meth. Prog. Biol. 1989; 30: 30–47.
34Martin, HJ. A revised measure of approval motivation and its relationship to social desirability. J. Pers. Assess. 1984; 48: 48–508.
35Marlowe, D, Crowne, D. Social desirability and responses to perceived situational demands. J. Consult. Clin. Psychol. 1961; 25: 25–109.
36Bradlow, HL, Sepkovic, DW, Klug, T, Osborne, MP. Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids 1998;63(7–8): 406–13.
37Hebert, JR, Hurley, T, Chiraboga, DE, Barone, JA. A comparison of selected nutrient intakes derived from three diet assessment methods used in a low-fat maintenance trial. Public Health Nutr. 1998; 1: 1–207.
38Buzzard, IM, Faucett, CL, Jeffrey, RW, McBane, L, McGovern, P, Baxter, JS, et al. Monitoring dietary change in a low-fat diet intervention study: advantages of using 24-hour dietary recalls vs food records. J. Am. Diet. Assoc. 1996; 96: 96–574.
39Fenwick, GR, Heaney, RK, Mullin, WJ. Glucosinolates and their breakdown products in food and food plants. In: CRC Critical Reviews in Food Science and Nutrition, 1983; 123–200.
40Steinmetz, KA, Kushi, LH, Bostick, RM, Folsom, AR, Potter, JD. Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am. J. Epidemiol. 1994; 139(1): 1–15.
41McDanell, R, McLean, AEM, Hanley, AB, Heaney, RK, Fenwick, GR. Differential induction of mixed-function oxidase activity in rat liver and intestine by diets containing processed cabbage: correlation with cabbage levels of glucosinolates and glucosinolate hydrolysis products. Food Chem. Tox. 1987; 25(5): 363–8.
42Howard, LA, Jeffrey, EH, Wallig, MA, Klein, BP. Retention of phytochemicals in fresh and processed broccoli. J. Food Sci. 1997; 62(6): 1098–100.
43Slominski, BA, Campbell, LD. Formation of indole glucosinolate breakdown products in autolyzed, streamed, and cooked Brassica vegetables. J. Agric. Food Chem. 1989; 37: 1297–302.
44Bjeldanes, LF, Kim, J-Y, Grose, KR, Bartholomew, JC, Bradfield, CA. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA 1991; 88: 9543–7.
45Kabat, GC, Chang, CJ, Sparano, JA, Sepkovic, DW, Hu, X-P, Khalil, A, et al. Urinary estrogen metabolites and breast cancer: a case–control study. Cancer Epidemiol. Biomark. Prev. 1997; 6: 6–505.
46Zheng, W, Dunning, L, Jin, F, Holtzman, J. Correspondence re: GC Kabat et al., Urinary estrogen metabolites and breast cancer: a case–control study. Cancer Epidemiol. Biomark. Prev. 1998: 7: 85–6.
47Bradlow, HL, Telang, NT, Sepkov, DW, Osborne, MP. 2-Hydroxyestrone: the 'good' estrogen. J. Endocrinol. 1996; 150: S256–65.
48Ursin, G, London, S, Stanczyk, FZ, Gentzchein, E, Paganini-Hill, A, Ross, RK, et al. Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. 1999; 91(12), 1067–72.
49Ho, GH, Luo, XW, Ji, CY, Foo, SC, Ng, EH. Urinary 2/16-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer. Ann. Acad. Med. Singapore 1998; 27: 294–9.
50Meilahn, E, DeStavola, B, Allen, D, Fentim, I, Bradlow, H, Sepkovic, D, et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br. J. Cancer 1998; 78(9): 1250–5.
51Walter-Sack, I, Klotz, U. Influence of diet and nutritional status on drug metabolism. Clin. Pharmacokinetics 1996; 31(1): 47–64.